An initiative launched by the American Heart Association in September aims to improve in-hospital patient care for patients with HFpEF and HFmrEF.

Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...

SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...

Cardiac rehabilitation improves function and survival after an event, yet women experience less referral and engagement rates ...

"We are headed down the road of increasing development and utilization of devices to treat heart failure," Dr. William ...

Ancora Heart, Inc., a medical device company developing a transcatheter device-based therapy to address heart failure (HF), ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...

Short-term exposure to low or high temperatures is linked to an increased likelihood of all-cause and cardiovascular disease ...

Intervening in the pathways that disrupt the brain’s waste clearance system could help prevent or slow Alzheimer’s disease ...

Background The minimally important difference (MID) for frailty variation associated with adverse outcomes remains unknown in ...

Women experiencing earlier menopause can affect heart health, and can together affect brain and cognitive performance, ...

A BMJ study found that individuals exposed to sugar rationing during their first 1,000 days of life had significantly lower ...